{'fraction_non_alphanumeric': 0.030013642564802184, 'fraction_numerical': 0.0, 'mean_word_length': 5.327586206896552, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Beta‐blockers for treatment of autoimmune blistering dermatosis

We read with interest a study by Miyamoto et al. published in the Journal of European Academy of Dermatology and Venereology. In their study, Miyamoto et al. found higher expression of vascular endothelial growth factor (VEGF) and endoglin in the tissue of erythrodermic pemphigus foliaceous (PF) compared to non-erythrodermic PF. According to the authors, both VEGF and endoglin may pose a prognostic predicting factors for adequate tissue repair in pemphigus patients; PF& pemphigus vulgaris (PV). The authors stated "therapy such as topical propranolol may enable adequate healing and disease remission". This article is protected by copyright. All rights reserved.